Non-invasive markers of fibrosis at 3 years of follow-up in liver transplant recipients with moderate/severe hepatitis C recurrence, successfully treated with DAAs

被引：0
|
作者：
Martini, S. [1 ]
Sacco, M. [1 ]
Testa, G. [1 ]
Calvo, F. [1 ]
Mirabella, S. [2 ,3 ]
Cocchis, D. [2 ,3 ]
Saracco, G. M. [1 ]
Romagnoli, R. [2 ,3 ]
机构：
[1] Univ Turin, AOU Citta Salute & Sci Torino, Gastrohepatol, Turin, Italy
[2] Univ Turin, AOU Citta Salute & Sci Torino, Liver Transplant Ctr, Turin, Italy
[3] Univ Turin, AOU Citta Salute & Sci Torino, Gen Surg 2U, Turin, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2019年 / 51卷
关键词：
D O I：
10.1016/j.dld.2018.11.135
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
F-19
引用
收藏
页码：E51 / E52
页数：2
相关论文
共 50 条
  • [1] Impact of successful DAA therapy at 3 years of follow-up in liver transplant recipients with hepatitis C recurrence and moderate/severe fibrosis
    Martini, Silvia
    Sacco, Marco
    Testa, Giulia
    Calvo, Federica
    Mirabella, Stefano
    Cocchis, Donatella
    Saracco, Giorgio Maria
    Romagnoli, Renato
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E138 - E139
  • [2] Prospective Non-Invasive Follow-Up of Liver Fibrosis in Patients with Chronic Hepatitis C
    Crisan, Dana
    Radu, Corina
    Grigorescu, Mircea Dan
    Lupsor, Monica
    Feier, Diana
    Grigorescu, Mircea
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (04) : 375 - 382
  • [3] Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C
    Crespo, Sergio
    Bridges, Mellena
    Nakhleh, Raouf
    McPhail, Andre
    Pungpapong, Surakit
    Keaveny, Andrew P.
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (05) : 652 - 658
  • [4] Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy
    Bedossa, Pierre
    [J]. LIVER INTERNATIONAL, 2009, 29 : 19 - 22
  • [5] A NEW NON-INVASIVE TOOL IN FOLLOW-UP MONITORING OF RENAL TRANSPLANT RECIPIENTS
    Vittoraki, Angeliki G.
    Darema, Maria N.
    Skordaki, Zoe Th
    Zachariou, Angeliki S.
    Kostakis, Alkiviadis J.
    Boletis, John N.
    Iniotaki, Aliki G.
    [J]. HUMAN IMMUNOLOGY, 2009, 70 : S68 - S68
  • [6] Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis C
    Leroy, Vincent
    Zarski, Jean-Pierre
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (05) : 881 - 883
  • [7] The use of transient elastography and non-invasive serum markers of fibrosis in pediatric liver transplant recipients
    Goldschmidt, Imeke
    Stieghorst, Henrik
    Munteanu, Mona
    Poynard, Thierry
    Schlue, Jerome
    Streckenbach, Carolin
    Baumann, Ulrich
    [J]. PEDIATRIC TRANSPLANTATION, 2013, 17 (06) : 525 - 534
  • [8] EARLY CHANGES IN NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN HEPATITIS C VIRUS-INFECTED PATIENTS TREATED WITH DAAS: PRELIMINARY REPORTS
    Iegri, C.
    Pasulo, L.
    Colpani, M.
    Baldan, A.
    Magini, G.
    De Giorgio, M.
    Gaffuri, G.
    Sangiovanni, L.
    Luca, M. G.
    Gibiino, G.
    Fagiuoli, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E238 - E239
  • [9] Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence
    Cross, Timothy J. S.
    Jothimani, Dinesh
    Heneghan, Michael A.
    Harrison, Phillip M.
    [J]. CLINICAL TRANSPLANTATION, 2011, 25 (03) : 345 - 351
  • [10] DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods
    Ravaioli, F.
    Tame, M. R.
    Marasco, G.
    Vizioli, L.
    Morelli, M. C.
    Pinna, A. D.
    Conti, F.
    Andreone, P.
    Colecchia, A.
    Festi, D.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S239 - S239
12345